InvaGen Pharmaceuticals, Inc., Ten Percent Owner at Avenue Therapeutics, holds 0.00 shares in Avenue Therapeutics (Ticker: ATXI). Most recently, InvaGen Pharmaceuticals, Inc. Sold $388,888 shares of Avenue Therapeutics on Oct 13, 2022 for an estimated value of 3.00M.

See the Hottest Stocks Based on Insider Trading >

InvaGen Pharmaceuticals, Inc.
Avenue Therapeutics (ATXI)
Ten Percent Owner

Not Ranked

InvaGen Pharmaceuticals, Inc. has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

InvaGen Pharmaceuticals, Inc. does not currently own shares as a corporate insider.

A breakdown of InvaGen Pharmaceuticals, Inc.'s holdings

See the Top Stocks by Insiders

Insider Roles

Avenue Therapeutics
(ATXI)

Ten Percent Owner

Roles that InvaGen Pharmaceuticals, Inc. holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Currently, no data available

The most profitable trade made by InvaGen Pharmaceuticals, Inc.

See the Latest Stocks Traded by Insiders

InvaGen Pharmaceuticals, Inc.'s Trading History

ATXI

Avenue Therapeutics

Oct 13, 2022

Ten Percent Owner

Informative Sell

3.00M

$0.00

Oct 13, 2022

Informative Sell

$3.00M

$7.71

―

List of latest transactions for each holding click on a transaction to see InvaGen Pharmaceuticals, Inc.'s performance on stock

See All Insider Trading from Today

InvaGen Pharmaceuticals, Inc. insider profile FAQ

What is the percentage of profitable transactions made by InvaGen Pharmaceuticals, Inc.?

The percentage of profitable transactions made by InvaGen Pharmaceuticals, Inc. is ―.

What is the average return per transaction made by InvaGen Pharmaceuticals, Inc.?

The average return per transaction made by InvaGen Pharmaceuticals, Inc. is ―.

What stocks does InvaGen Pharmaceuticals, Inc. hold?

InvaGen Pharmaceuticals, Inc. holds: ATXI stocks.

What was InvaGen Pharmaceuticals, Inc.’s latest transaction?

InvaGen Pharmaceuticals, Inc. latest transaction was an Informative Sell of $3.00M.

What was InvaGen Pharmaceuticals, Inc.'s most profitable transaction?

InvaGen Pharmaceuticals, Inc.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.

What is InvaGen Pharmaceuticals, Inc.'s role in Avenue Therapeutics?

InvaGen Pharmaceuticals, Inc.'s role in Avenue Therapeutics is Ten Percent Owner.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

InvaGen Pharmaceuticals, Inc. Insider Profile

InvaGen Pharmaceuticals, Inc. Avenue Therapeutics (ATXI)Ten Percent Owner